A library of peptide research, organized by hub.
Five subject hubs: peptide science fundamentals, analytical quality, evidence standards, compound profiles by pathway, and regulatory science. Every article separates molecule-level evidence from product-level status.
Regulatory Science
Compounding regulation, intended-use doctrine, advisory committees, and editorial frameworks.
How to Write Responsible Scientific Product Content
Responsible scientific content explains identity, mechanism, evidence, limitations, and status without converting early research into a consumer promise.
Read articleWhy Laboratory Research and Human Administration Must Stay Separate
A reagent can support a valid experiment without being suitable for administration. Human use requires a different evidence, quality, oversight, and consent framework.
Read articleWhat FDA's 2026 Compounding Advisory Agenda Signals for Several Research Peptides
An advisory-committee agenda signals active regulatory evaluation. It is neither an approval nor a final prohibition, and the outcome must be reported after the meeting.
Read articleThe 503A Bulks List and Why Researchers Should Follow It
The 503A bulks process addresses whether certain substances may qualify for pharmacy compounding under defined conditions. It does not approve them as drugs.
Read articleWhy Peptide-Related Impurities Receive Regulatory Attention
Peptide impurities may differ from the intended sequence by only one residue or modification while retaining biological or immune activity.
Read articleThe Difference Between an Approved Active Ingredient and an Approved Product
A molecule can appear in an approved medicine while another product containing a similarly named ingredient remains unapproved, non-equivalent, or poorly characterized.
Read articleWhy Compounded Drugs Are Not FDA-Approved Drugs
Compounding can serve legitimate patient needs under defined legal conditions, but compounded products do not undergo FDA premarket approval.
Read articleWhat FDA's Peptide Clinical Pharmacology Guidance Means for Researchers
FDA's peptide guidance shows how many variables must be understood before peptide evidence can support a development program.
Read articleHow FDA Evaluates Intended Use for Online Research Products
FDA can infer intended use from the full commercial record, including what a company says, shows, bundles, links, and encourages customers to do.
Read articleResearch Use Only Does Not Mean Regulation-Free
Research-use language is one fact in a broader regulatory analysis. Regulators evaluate the product, claims, audience, accessories, and commercial context together.
Read article